Connect With a Global Community of Experts
From discovery and preclinical research to manufacturing, regulatory strategy, CMC and investment, the 5th iPSC Drug Development Summit was your most comprehensive platform to engage with cross-functional stakeholders advancing iPSC-derived therapies toward the clinic and beyond.
This meeting uniquely brought together experts from across the iPSC therapy value chain spanning R&D, process development, regulatory affairs, and business development to openly discuss shared challenges and solutions for genetically stable, scalable, and clinically efficacious iPSC-derived therapies. With leading voices from Astellas Pharma, Sana Biotechnology, BlueRock Therapeutics, Novo Nordisk, GC Therapeutics, and Kenai Therapeutics, this was your opportunity to align on technical priorities and forge lasting, strategic partnerships across therapeutic areas.
Why Partner With The Summit in 2026?
Targeted Exposure to Decision-Makers
Engage directly with senior leaders and technical experts from leading iPSC drug developers actively seeking solutions to advance their programs toward the clinic
Position Your Brand as a Key Enabler
Showcase your capabilities and thought leadership at the industry’s longest-standing iPSC-dedicated forum, where your solutions can directly address pressing CMC, preclinical, and manufacturing needs
Accelerate Commercial Opportunities
Gain insider insights into current project bottlenecks and pipeline priorities to better tailor your innovations and build high-value, long-term partnerships
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.